NFJ Investment Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02K Hold
63
﹤0.01% 198
2026
Q1
$2.31K Hold
63
﹤0.01% 211
2025
Q4
$3.21K Hold
63
﹤0.01% 218
2025
Q3
$3.5K Sell
63
-85,925
-100% -$5.03M ﹤0.01% 254
2025
Q2
$5.93M Sell
85,988
-8,027
-9% -$546K 0.21% 122
2025
Q1
$6.53M Buy
94,015
+83,872
+827% +$6.93M 0.22% 109
2024
Q4
$873K Buy
10,143
+4,779
+89% +$517K 0.03% 247
2024
Q3
$639K Buy
+5,364
New +$715K 0.02% 246

Other funds holding NVO

NFJ Investment Group's NVO Position: Q2 2026 in Review

NFJ Investment Group held its Novo Nordisk (NVO) position steady in Q2 2026 at 63 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #198.

NFJ Investment Group first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.53M in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • NFJ Investment Group held 63 shares of Novo Nordisk worth $3.02K as of Q2 2026.
  • NFJ Investment Group left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of NFJ Investment Group's portfolio in Q2 2026, its #198 holding.
  • NFJ Investment Group first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
  • NFJ Investment Group's Novo Nordisk position peaked at $6.53M in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.